Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
viral vectors
Biotech
Ring lays off nearly half of staff, CEO to exit in new year
The Flagship-backed biotech developing new viral vectors for gene therapy delivery has cut its staff by just under 50%, a spokesperson confirmed.
Darren Incorvaia
Dec 18, 2024 2:31pm
GSK axes hepatitis B vaccine trial after missing efficacy goal
Dec 4, 2024 5:15am
Ring's 'new class of viral vector' is re-dosable in primates
May 8, 2024 5:05pm
Ring's new human viral vector delivers gene to retinas of mice
Apr 2, 2024 8:10am
ViroCell gets UK nod to produce viral vectors at London facility
Nov 2, 2023 9:50am
Astellas to test out 4DMT's eye disease gene therapy vector
Jul 10, 2023 7:30pm
